White House Pulls Heidi Overton's FDA Nomination Before Wednesday Vote Amid Bipartisan Senate Opposition
Updated
Updated · The Washington Post · Nov 18
White House Pulls Heidi Overton's FDA Nomination Before Wednesday Vote Amid Bipartisan Senate Opposition
3 articles · Updated · The Washington Post · Nov 18
Summary
Heidi Overton's nomination to lead the FDA was withdrawn before a Wednesday Senate HELP Committee vote after White House officials concluded she likely could not win confirmation.
Bipartisan resistance drove the decision: Democrats opposed her, GOP senators raised doubts, and committee chair Bill Cassidy said Sunday he still had "questions" about her fitness for the job.
Overton drew scrutiny over vaccines, abortion-pill policy and fruit-flavored vapes, while some Robert F. Kennedy Jr.-aligned MAHA activists also attacked her as too friendly to corporate interests.
The withdrawal leaves the FDA without a Senate-confirmed commissioner since Marty Makary resigned in May, with acting chief Kyle Diamantas now likely to remain in place as Democrats prepare to control Congress next year.